The RheOx ® system for the treatment of the symptoms of chronic bronchitis consists of a proprietary electrosurgical generator and a single-use catheter. The minimally-invasive bronchoscopic therapy delivers short bursts of Pulsed Electric Field (PEF) energy to induce non-thermal ablation of the abnormal mucus-producing cells in the airways ...

What is Bronchial Rheoplasty? This is a device therapy being studied for patients with COPD and chronic sputum production. In the study, a small tube called a bronchoscope is placed in the lungs under anesthesia. Through that, a catheter is introduced, and non-heat pulsed electrical stimulation is applied to mucus secreting cells in the lungs.

Bronchial rheoplasty is a procedure that uses nonthermal pulsed electrical fields with the intention of ablating the abnormal mucus-producing cells of the airway epithelium, thereby allowing normal, healthy epithelial regeneration to occur.

Right now, doctors at our research center are conducting a new research study of Bronchial Rheoplasty using RheOx™, an investigational device designed to reduce cough and mucus production through a minimally-invasive procedure.

Sep 4, 2020 · RheOx is a bronchoscopic system designed to reduce mucus-producing cells in patients with chronic bronchitis. The technology includes an electrosurgical generator and a single-use catheter that together deliver non-thermal energy to the airways to reduce the number of abnormal mucus-producing cells in the lungs, making way for new normal cells ...

Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures …

Aug 17, 2020 · Antibiotics and steroids can give short-term relief, but there's no cure for chronic bronchitis, and long-term treatments have been limited. Temple is one of the U.S. sites testing a new option...

Dec 26, 2023 · Bronchial rheoplasty (BR) with the RheOx system delivers non-thermal pulsed electric fields to the lower airway epithelium and submucosa to reduce mucus producing cells. Early phase clinical trials including 1-year follow-up have demonstrated reduction in airway goblet cell hyperplasia and improvement in CB symptoms.

Sep 17, 2019 · RheOx is a bronchoscopic system designed to reduce mucus-producing cells in patients with Chronic Bronchitis. The revolutionary technology includes an electrosurgical generator and a single-use catheter that together deliver non-thermal energy to the airways to reduce the number of abnormal mucus-producing cells in the lungs, making way for new ...

Sep 4, 2019 · The RheOx Bronchial Rheoplasty system delivers non-thermal energy to the airways to reduce mucus-producing cells in patients with chronic bronchitis.